EGT

2-(3,4,5-TRIHYDROXY-PHENYL)-CHROMAN-3,5,7-TRIOL

Created:	2001-08-14
Last modified:	2021-03-01

Find Related PDB Entry
3 entries where EGT is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	36
Chiral Atom Count	2
Bond Count	38
Aromatic Bond Count	12

2D diagram of EGT

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-(3,4,5-TRIHYDROXY-PHENYL)-CHROMAN-3,5,7-TRIOL
Synonyms	EPIGALLOCATECHIN
Systematic Name (OpenEye OEToolkits)	(2R,3R)-2-(3,4,5-trihydroxyphenyl)chroman-3,5,7-triol
Formula	C₁₅ H₁₄ O₇
Molecular Weight	306.267
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	Oc1cc(cc(O)c1O)C3Oc2cc(O)cc(O)c2CC3O
SMILES	CACTVS	3.341	O[CH]1Cc2c(O)cc(O)cc2O[CH]1c3cc(O)c(O)c(O)c3
SMILES	OpenEye OEToolkits	1.5.0	c1c(cc(c(c1O)O)O)C2C(Cc3c(cc(cc3O2)O)O)O
Canonical SMILES	CACTVS	3.341	O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3cc(O)c(O)c(O)c3
Canonical SMILES	OpenEye OEToolkits	1.5.0	c1c(cc(c(c1O)O)O)[C@@H]2[C@@H](Cc3c(cc(cc3O2)O)O)O
InChI	InChI	1.03	InChI=1S/C15H14O7/c16-7-3-9(17)8-5-12(20)15(22-13(8)4-7)6-1-10(18)14(21)11(19)2-6/h1-4,12,15-21H,5H2/t12-,15-/m1/s1
InChIKey	InChI	1.03	XMOCLSLCDHWDHP-IUODEOHRSA-N

Drug Info: DrugBank

DrugBank ID	DB03823
Name	Epigallocatechin
Groups	investigational experimental
Synonyms	(-)-epigallocatechol Epi-gallocatechin Antiscurvy factor C2 (-)-epi-gallocatechin Galloepicatechin 3,3',4',5,5',7-flavanhexol (-)-epigallocatechin Epigallocatechin EGC L-epigallocatechin (−)-epigallocatechin
Categories	Benzopyrans Chromans Chromones Flavonoids Heterocyclic Compounds, Fused-Ring Pyrans
CAS number	970-74-1

Related Resource References

Resource Name	Reference
PubChem	72277
ChEMBL	CHEMBL47386
ChEBI	CHEBI:42255

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.